StocksMedium•5 November 2026•
1 min read
Intellia Therapeutics Reports Wider-Than-Expected Q3 Loss
Key Facts
1Intellia Therapeutics reported a quarterly loss of $0.91 per share, wider than the analyst consensus estimate of a loss of $0.82.
2The current quarter's loss compares to a loss of $0.92 per share reported in the same period a year ago.
Intellia Therapeutics reported a quarterly loss of $0.91 per share for the third quarter. Zacks reported that the loss was wider than the analyst consensus estimate of $0.82 per share.
The current performance compares to a loss of $0.92 per share reported in the same period a year ago. Shares of Intellia Therapeutics, trading under the ticker NTLA, closed at $12.31 on November 4, 2026.